Table 1 Baseline characteristics of mildly depressed women with type 2 diabetes who completed the trial
Controls (n = 6) | Paroxetine (n = 7) | |||
|---|---|---|---|---|
Mean | SD | Mean | SD | |
Age (years) | 62.3 | 11.5 | 61.1 | 8.6 |
Body mass index (kg/m2) | 30.1 | 6.3 | 31.6 | 3.0 |
Metabolic parameters | ||||
Fasting blood glucose (mmol/l) | 8.4 | 1.3 | 8.9 | 2.8 |
HbA1c (%) | 6.9 | 0.4 | 7.5 | 0.8 |
S-cholesterol (mmol/l) | 5.5 | 1.4 | 5.8 | 1.0 |
HDL cholesterol (mmol/l) | 1.6 | 0.4 | 1.4 | 0.2 |
LDL cholesterol (mmol/l) | 3.0 | 1.2 | 3.7 | 0.9 |
S-triglycerides (mmol/l) | 2.1 | 1.1 | 1.5 | 0.7 |
Free fatty acids (mmol/l) | 0.9 | 0.4 | 1.0 | 0.2 |
Sex hormone binding globulin (nmol/l) | 74.2 | 34.3 | 38.9 | 19.5 |
S-leptin (ng/ml) | 32.2 | 14.9 | 22.9 | 15.2 |
S-cortisol (nmol/l) | 460.2 | 130.0 | 550.7 | 120.7 |
Energy expenditure (kcal/d) | 1516.7 | 167.7 | 1658.6 | 246.5 |
Mental status | ||||
Hamilton's Anxiety Scale | 9.3 | 3.7 | 13.7 | 4.2 |
Montgomery-Åsberg's Depression Rating Scale | 6.4 | 4.0 | 7.4 | 2.9 |
Beck's Depression Inventory | 13.0 | 9.2 | 13.7 | 7.4 |
RAND-36 | 436.8 | 182.0 | 455.6 | 142.7 |